Study identifier:NIS-CEU-DUM-2006/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Prevalence of peripheral Arterial disease in subjects with a moderate CVD risk, with No overt vascular Diseases nOR diAbetes mellitus
Peripheral Arterial Disease (PAD)
-
No
-
All
9000
Observational
45 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
1 Subjects of either sex, any race, with at least two CVD risk factors, with no overt cardiovascular diseases nor diabetes mellitus | - |